BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6789255)

  • 1. [Syndrome caused by ovarian hyperstimulation and pregnancy].
    Zinelli G
    Minerva Ginecol; 1981; 33(2-3):271-8. PubMed ID: 6789255
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT; Ohlinger R
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian hyperstimulation syndrome: a current survey.
    Schenker JG; Weinstein D
    Fertil Steril; 1978 Sep; 30(3):255-68. PubMed ID: 361440
    [No Abstract]   [Full Text] [Related]  

  • 4. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
    Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ
    BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follicular recruitment is reduced in minimal stimulation for controlled ovarian hyperstimulation using purified human menopausal gonadotropin compared with follicle-stimulating hormone.
    Park JK; Clark R; Session DR
    Fertil Steril; 2009 Apr; 91(4 Suppl):1434-6. PubMed ID: 18701097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
    Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY
    Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose follicle stimulating hormone for ovulation induction in polycystic ovary syndrome.
    Strowitzki T; Seehaus D; Korell M; Hepp H
    J Reprod Med; 1994 Jul; 39(7):499-503. PubMed ID: 7966037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lateral medullary syndrome in a woman after ovulation induction.
    Lin HC; Chen MJ; Chou CH; Young YH
    Auris Nasus Larynx; 2007 Sep; 34(3):383-5. PubMed ID: 17344003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assisted reproduction and risks of superovulation].
    Seppälä M; Tiitinen A; Teramo K; Raivio K
    Duodecim; 1996; 112(4):245-7. PubMed ID: 10590636
    [No Abstract]   [Full Text] [Related]  

  • 10. The History of the Florentine sextuplets: obstetric and genetic considerations.
    Giovannucci-Uzielli ML; Vecchi C; Donzelli GP; D'Ancona VL; Lapi E
    Prog Clin Biol Res; 1981; 69A():217-20. PubMed ID: 6795648
    [No Abstract]   [Full Text] [Related]  

  • 11. Patient-tailored conventional ovulation induction algorithms in anovulatory infertility.
    van Santbrink EJ; Eijkemans MJ; Laven JS; Fauser BC
    Trends Endocrinol Metab; 2005 Oct; 16(8):381-9. PubMed ID: 16129615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of estradiol to progesterone for luteal supplementation in patients stimulated with GnRH antagonist/rFSH for IVF: a randomized controlled trial.
    Fatemi HM; Kolibianakis EM; Camus M; Tournaye H; Donoso P; Papanikolaou E; Devroey P
    Hum Reprod; 2006 Oct; 21(10):2628-32. PubMed ID: 16857887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel protocol of ovulation induction with delayed gonadotropin-releasing hormone antagonist administration combined with high-dose recombinant follicle-stimulating hormone and clomiphene citrate for poor responders and women over 35 years.
    D'Amato G; Caroppo E; Pasquadibisceglie A; Carone D; Vitti A; Vizziello GM
    Fertil Steril; 2004 Jun; 81(6):1572-7. PubMed ID: 15193479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [From ACS-180 to Advia-Centaur (Bayer diagnostics): assessment of estradiol, progesterone, LH and FSH assays].
    Taieb J; Benattar C; Birr AS; Po s C
    Ann Biol Clin (Paris); 2003; 61(2):223-8. PubMed ID: 12702480
    [No Abstract]   [Full Text] [Related]  

  • 15. [How to prevent completely ovarian hyperstimulation with GnRH-based stimulation protocols].
    Kol S
    Akush Ginekol (Sofiia); 2001; 40(4):36-41. PubMed ID: 11803870
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ovulation induction in general practice--possibilities and limits].
    Reichel R
    Gynakol Geburtshilfliche Rundsch; 1995; 35(1):56-7. PubMed ID: 7727979
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of metformin supplementation during ovarian stimulation of lean PCOS patients undergoing in vitro fertilization.
    Kumbak B; Kahraman S
    Acta Obstet Gynecol Scand; 2009; 88(5):563-8. PubMed ID: 19306135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphene citrate as adjuvants to recombinant follicle-stimulating hormone in controlled ovarian hyperstimulation: a prospective, randomized, blinded clinical trial.
    Barroso G; Menocal G; Felix H; Rojas-Ruiz JC; Arslan M; Oehninger S
    Fertil Steril; 2006 Nov; 86(5):1428-31. PubMed ID: 16978619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic value of basal hormone levels on ovarian reserve].
    Zhao X; Zhang L; Gong S
    Zhonghua Fu Chan Ke Za Zhi; 1998 Jun; 33(6):334-6. PubMed ID: 10806668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute intermittent porphyria associated with ovarian stimulation. A case report.
    Seiden WB; Kelly LP; Ali R
    J Reprod Med; 2003 Mar; 48(3):201-3. PubMed ID: 12698780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.